Alvotech, Lotte Biologics Ink US Manufacturing Deal
Alvotech and Lotte Biologics have signed a US-based manufacturing agreement aimed at increasing global supply.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Alvotech and LOTTE Biologics Sign US Manufacturing Deal
Alvotech and LOTTE Biologics have entered into a US-based manufacturing agreement to increase global supply of biosimilar products. The collaboration will leverage LOTTE Biologics' Syracuse, New York facility and aims to expand Alvotech's manufacturing capacity to meet growing demand.